Actithera, Inc.

Actithera is a radiopharmaceutical biotech company that designs and develops next-generation radioligand therapies (RLTs) to treat cancer. Using proprietary medicinal chemistry, including covalent-targeting and an isotope-agnostic philosophy, the company creates targeted therapies that maximize tumor radiation dose while minimizing exposure to healthy tissues to improve the lives of cancer patients with high unmet medical needs.